WHOOP Raises $575 Million at $10.1 Billion Valuation, Nearly Tripling Its Worth as AI Health Platform Scales Globally

Fitness and health tracking company WHOOP closed a $575 million Series G on March 31, 2026, at a $10.1 billion valuation, nearly three times its last reported valuation of $3.6 billion. The round was led by Collaborative Fund and brings together an investor group that is unusual for its range of institutional credibility: sovereign wealth funds, major health institutions, and some of the most recognizable athletes on the planet.

The institutional investor list reads like a who's who of global capital: Qatar Investment Authority (QIA), Mubadala Investment Company, Abbott, Mayo Clinic, Macquarie Capital, IVP, Foundry Group, Accomplice, Glade Brook, Affinity Partners, B‑Flexion, Promus Ventures, and Bullhound Capital. Individual investors include Cristiano Ronaldo, LeBron James, Rory McIlroy, Virgil van Dijk, Reggie Miller, and Niall Horan, among others. The presence of Abbott and Mayo Clinic as strategic investors is particularly significant. They bring deep healthcare expertise and a track record of health tech innovation that separates this round from typical consumer tech raises.

The commercial story underlying the valuation is real. WHOOP entered 2026 with:

• More than 2.5 million members globally, shipping to 56 countries in six languages
• A $1.1 billion revenue run rate, up 103% year over year in bookings as of the end of 2025
• Cash‑flow positive operations, achieved during 2025
• More than 8 app sessions per day per user, nearly three times the engagement of comparable screenless wearable devices

That last metric is often the most underappreciated. WHOOP is not a device people wear and occasionally check. It is a platform people return to multiple times a day because the data it produces changes how they make decisions about sleep, training, recovery, and long‑term health habits.

The product underpinning this engagement is built on more than 24 billion hours of physiological data and a suite of purpose‑built AI models that convert raw biometric readings into actionable guidance. The feature set goes considerably beyond basic fitness tracking. WHOOP includes an FDA‑cleared ECG, a Healthspan longevity feature that tracks biological age against chronological age, Blood Pressure Insights for ongoing cardiovascular monitoring, and Advanced Labs for blood biomarker analysis. Clinical research shows measurable behavioral change: daily wearers log more than 90 additional minutes of exercise per week, get over two extra hours of sleep per night, and show 10% higher heart rate variability at baseline.

The company is now entering a different phase of ambition than the one that built its initial user base among elite athletes and health‑focused consumers. The $575 million will fuel expansion into Europe, the Gulf Cooperation Council countries, Latin America, and Asia, along with the hiring of more than 600 new employees globally to support that geographic growth and deepen the AI capabilities of the platform.

Will Ahmed, founder and CEO, described the raise as bringing together the world's most sophisticated investors, leading health institutions, and iconic global athletes behind the mission to unlock human performance and healthspan. That language, healthspan rather than just health or fitness, signals where WHOOP sees its long‑term positioning: not as a fitness tracker but as a proactive health system designed to extend the years of life that people actually feel well enough to live fully.

The competitive landscape includes Oura Ring, valued at approximately $11 billion, Apple Watch, and Garmin. What WHOOP has that none of those competitors matches is the combination of clinical institutional partnerships, a screenless design that removes phone‑like distraction, and an AI coaching layer trained on a proprietary physiological dataset that has been accumulating for over a decade.

The Abbott and Mayo Clinic investments deserve elaboration because they represent something qualitatively different from the athlete or sovereign wealth fund participants. Abbott is one of the world's largest medical device and diagnostics companies, with a portfolio spanning blood glucose monitoring, cardiac devices, nutrition science, and diagnostics. Its involvement as a strategic investor signals that WHOOP's platform is becoming relevant not just to elite athletes and health‑conscious consumers but to the clinical and diagnostic ecosystem where validated health data has regulatory, insurance, and medical decision‑making implications.

Mayo Clinic brings an equivalent form of credibility from the healthcare delivery side. As one of the most trusted and research‑intensive health systems in the United States, Mayo Clinic's investment in a consumer wearable company is a statement that the data WHOOP generates has clinical relevance that extends beyond lifestyle optimization. The partnership creates a pathway for WHOOP's physiological insights to be studied, validated, and potentially integrated into clinical care pathways in ways that most consumer health platforms have never achieved.

For the broader wearable health market, WHOOP's $575 million raise and $10.1 billion valuation at a moment of genuine commercial health, positive cash flow and 103% booking growth, makes it one of the most credible bets in consumer health technology that institutional capital has placed in recent memory. The company is not raising money to fund losses while hunting for a business model. It is raising money to expand a business model that is already working at a billion‑dollar revenue run rate across a global subscriber base that is actively changing health behaviors.

Will Ahmed, who founded the company as a Harvard undergraduate athlete frustrated by his inability to understand how his training load was affecting his performance and recovery, has built WHOOP into one of the defining consumer health technology businesses of this decade. The question now is whether the global expansion and the deepened AI health capabilities that this round funds can take the platform from 2.5 million members to a scale where WHOOP is genuinely mainstream rather than a premium product for those who already care deeply about their health metrics.

Official Sources: WHOOP